Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Institute of Biomedi (OP:MRES)

0.0038 +0.0007 (+22.58%)
Streaming Delayed Price Updated: 3:36 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Institute of Biomedi

News headline image
MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences
Via ACCESSWIRE
News headline image
MRES: M2Bio Food and Beverage Refocuses Strategy: Expanding Beyond CBD to Reach Global Consumers
Via ACCESSWIRE
News headline image
MRES: M2Bio Sciences Provides Corporate Update
Via ACCESSWIRE
News headline image
MRES: M2Bio Sciences Introduces M2BioKids: A Pioneering Approach to Elevating Childhood Health and Development
Via ACCESSWIRE
News headline image
MRES: M2Enviro 2023 Year-End Review and 2024 Looking Forward
Via ACCESSWIRE
News headline image
MRES: M2Biome 2023 Year-End Review and 2024 Looking Forward
Via ACCESSWIRE
News headline image
Real American Announces Acquisition of M2MMA from MRES
Via ACCESSWIRE
News headline image
MRES: M2MMA Gears Up for a Landmark Year in 2024
Via ACCESSWIRE
News headline image
MRES: M2Bio Sciences Expands Global Presence with New Offices in Dubai Science Park
Via ACCESSWIRE
News headline image
MRES: M2Bio Sciences Marks Milestone Expansion with Launch of Los Angeles Office
Via ACCESSWIRE
News headline image
African Ginger Patented for Influenza and SARS-CoV-2 Treatment: Insights from M2Bio Sciences Research Chair
Via ACCESSWIRE
News headline image
M2MMA Announces 2024 Fight Schedule and Appoints CEO
Via ACCESSWIRE
News headline image
M2Bio Sciences Chair, Prof Maharaj, to Deliver Keynote Address on Cutting-Edge Biotechnology Advancements
Via ACCESSWIRE
News headline image
M2Bio Sciences Closes JDAX Acquisition
Via ACCESSWIRE
News headline image
M2Bio Sciences Pharmacology & Clinical Application of CBD
Via ACCESSWIRE
News headline image
M2Bio-Discovery Centre for AI-Driven Phytomedicine Research: Update
Via ACCESSWIRE
News headline image
M2bio Sciences Announces Launch of Exclusive MMA Organization
Via ACCESSWIRE
BioMedNewsBreaks – Institute of Biomedical Research Corp. (MRES) Names Veteran Financial Leader to Advisory Board
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks – Institute of Biomedical Research Corp. (MRES) Unveils Meticulously Crafted Line of Teas Sourced from Kenya
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
AI-Powered Psychedelic Treatments: Special Status And Next-Gen Contests Winners ↗
As psychedelics and AI travel their own development paths, here are some initiatives looking at ways of enhancing the former with the latter’s help. 
Via Benzinga
News headline image
M2Bio Sciences Division M2Biome Cardiometabolic Health Launches Website
M2Bio Sciences Division M2Biome Cardiometabolic Health Launches Website 
Via News Direct
M2Bio Sciences Division M2Biome Cardiometabolic Health Launches Website
Institute of Biomedical Research (OTC: MRES) ("M2Bio Sciences'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is... 
Via TheNewswire.com
News headline image
Innovative Holdings Alliance, Inc. Announces Brand License Agreement with M2Bio Sciences
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.